文献速递肿瘤 PET/CT

手术切除头颈部恶性肿瘤中[18F]FDG摄取与组织病理学的直接共配准:可行性研究

Direct co-registration of [18F]FDG uptake and histopathology in surgically excised malignancies of the head and neck: a feasibility study.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2023-03-01

本研究纳入5例头颈部恶性肿瘤患者,术前注射临床活度[18F]FDG后手术切除标本,先后用临床前高分辨率PET/CT和micro-PET/CT成像,并将冷冻切片进行放射自显影和HE染色,通过迭代共配准算法实现放射自显影与组织病理学的直接共配准。所有标本共配准均成功,该方法可直观显示良恶性组织中[18F]FDG摄取的未知异质性。

要点

  • 5例头颈部恶性肿瘤患者术前注射[18F]FDG,切除标本行高分辨率PET/CT和micro-PET/CT成像。
  • 放射自显影与组织病理学共配准在所有标本中均成功。
  • 该方法可显示良恶性组织中[18F]FDG摄取的未知异质性。

核心结论

  • 作者描述了一种新方法,可实现[18F]FDG放射自显影与人类恶性组织组织病理学金标准的直接共配准。
  • 作者认为未来使用该方法可能进一步加深对手术切除恶性肿瘤中放射性核素分布的理解,并从多尺度角度改善病理学与分子影像的整合。

研究设计与样本

  • 可行性研究,共纳入5例诊断为头颈部恶性肿瘤的患者。
  • 患者术前注射临床活度[18F]FDG后行手术切除。
  • 切除标本用临床前高分辨率PET/CT成像,随后切片,多张切片用micro-PET/CT重新扫描,其中一张切片速冻用于冷冻切片。
  • 冷冻切片置于放射自显影胶片上,随后行苏木精-伊红染色以供组织病理学评估。
  • 放射自显影与组织病理学结果使用迭代共配准算法进行共配准,并识别感兴趣区以研究放射性示踪剂摄取。

主要发现

  • 放射自显影与其对应组织病理学的共配准在所有标本中均成功。
  • 该新方法允许放射自显影与组织病理学的直接比较,并可视化良性和恶性组织中[18F]FDG摄取的未知异质性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Recent technical advancements in PET imaging have improved sensitivity and spatial resolution. Consequently, clinical nuclear medicine will be confronted with PET images on a previously unfamiliar resolution. To better understand [18F]FDG distribution at submillimetric scale, a direct correlation of radionuclide-imaging and histopathology is required. METHODS: A total of five patients diagnosed with a malignancy of the head and neck were injected with a clinical activity of [18F]FDG before undergoing surgical resection. The resected specimen was imaged using a preclinical high-resolution PET/CT, followed by slicing of the specimen. Multiple slices were rescanned using a micro-PET/CT device, and one of the slices was snap-frozen for frozen sections. Frozen sections were placed on an autoradiographic film, followed by haematoxylin and eosin staining to prepare them for histopathological assessment. The results from both autoradiography and histopathology were co-registered using an iterative co-registration algorithm, and regions of interest were identified to study radiotracer uptake. RESULTS: The co-registration between the autoradiographs and their corresponding histopathology was successful in all specimens. The use of this novel methodology allowed direct comparison of autoradiography and histopathology and enabled the visualisation of uncharted heterogeneity in [18F]FDG uptake in both benign and malignant tissue. CONCLUSION: We here describe a novel methodology enabling the direct co-registration of [18F]FDG autoradiography with the gold standard of histopathology in human malignant tissue. The future use of the current methodology could further increase our understanding of the distribution of radionuclides in surgically excised malignancies and hence, improve the integration of pathology and molecular imaging in a multiscale perspective. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05068687.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Debacker JM, Maris L, Cordier F, et al. Direct co-registration of [18F]FDG uptake and histopathology in surgically excised malignancies of the head and neck: a feasibility study. Eur J Nucl Med Mol Imaging. 2023. PMID: 36854863. doi:10.1007/s00259-023-06153-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。